| |
| |
|
| Insider
Information: |
Horak Ivan D |
| Relationship: |
EVP, R&D, CSO |
| City: |
Morris Plains |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
138,476 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$13,141 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,476 |
|
|
| Total
Value |
$13,141 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enzon Pharmaceuticals Inc |
ENZN |
EVP, R&D, CSO |
2011-04-03 |
138,476 |
2005-10-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
EVP-R&D & Chief Scien. Officer |
• – – |
2005-10-04 |
4 |
B |
$7.18 |
$39,490 |
D/D |
5,500 |
5,500 |
2.74 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP-R&D & Chief Scien. Officer |
• – – |
2006-03-07 |
4 |
B |
$6.86 |
$20,605 |
D/D |
3,000 |
8,500 |
2.74 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D & Ch. Scientific Off. |
• – – |
2007-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
33,500 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Ofc |
• – – |
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
91,000 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Ofc |
• – – |
2008-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
106,000 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Off |
• – – |
2008-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
108,250 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Off |
• – – |
2009-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,860 |
128,977 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Off |
• – – |
2009-04-03 |
4 |
S |
$6.12 |
$43,054 |
D/D |
(7,035) |
122,924 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Sci Officer |
• – – |
2009-09-02 |
4 |
D |
$7.58 |
$40,273 |
D/D |
(5,313) |
132,611 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Sci Officer |
• – – |
2009-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
137,924 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Sci. Officer |
• – – |
2009-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
134,861 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Sci. Officer |
• – – |
2009-11-23 |
4 |
D |
$10.37 |
$8,265 |
D/D |
(797) |
134,064 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Off |
• – – |
2010-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
134,064 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, Chief Scientific Off |
• – – |
2010-01-17 |
4 |
D |
$10.91 |
$109,678 |
D/D |
(10,053) |
124,011 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP,R&D, CSO |
• – – |
2010-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
16,465 |
140,476 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-02-22 |
4 |
S |
$9.30 |
$942,578 |
D/D |
(101,329) |
39,147 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
President of R&D |
• – – |
2010-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,860 |
59,007 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
President of R&D |
• – – |
2010-04-03 |
4 |
D |
$10.48 |
$73,727 |
D/D |
(7,035) |
51,972 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-02 |
4 |
D |
$10.58 |
$74,949 |
D/D |
(7,084) |
64,888 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
71,972 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-15 |
4 |
OE |
$6.97 |
$495,278 |
D/D |
70,200 |
135,088 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-15 |
4 |
S |
$10.81 |
$618,200 |
D/D |
(57,200) |
77,888 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-16 |
4 |
OE |
$7.14 |
$14,280 |
D/D |
2,000 |
79,888 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-16 |
4 |
S |
$10.67 |
$18,132 |
D/D |
(1,700) |
78,188 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
EVP, R&D, CSO |
• – – |
2010-09-17 |
4 |
OE |
$7.14 |
$1,748,472 |
D/D |
242,000 |
320,188 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
